Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performers have companies in phase III, according to Biotech Scandinavia's survey....

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Analys av metaboliter hjälp för att skräddarsy behandlingar

Genom att studera kroppens nedbrytningsprodukter, metaboliter, kan behandlingar bättre skräddarsys för patientens specifika behov och förutsättningar. Det säger...

Ny vd på Medcap

I november tar Anders Dahlberg över rodret på bolaget.

Sales Representative, Applied Biosystems

Enjoy Stockholm - the capital of Scandinavia

Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...

Flera välkända namn vid möte om diagnostik

Från det nya regelverket om in-vitrodiagnostik, IVDR, till nya sätt att utforska proteiner i blodet i samband med cancer. De är bara några av de ämnena som komm...

Labbmöte går av stapeln på Stockholmsmässan

Life Science Swedens möte om labb och diagnostik Lab & Diagnostics of the Future hålls nästa vecka på Swedish Labdays på Stockholmsmässan i Älvsjö.

Svensk forskare på global "power list"

Den svenska forskaren Evelina Vågesjö, medgrundare och vd för Ilya Pharma, har placerats på den amerikanska tidskriften The Medicine Makers "power list 2021".

Martin Willner, Manager Lab, Nordic Service Manager, Mettler-Toledo AB

Why are you going to Scanlab+Biotech Forum?

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

Webinar: Clinical evaluation and clinical investigation of medical devices

Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...

Kvinnohälsa en outnyttjad marknad – ”Det finns goda kommersiella möjligheter”

Mer och mer sker inom området kvinnohälsa när det kommer till både innovation och investeringar. Förutom att vara en viktig marknad är det även en relativt outn...

Showroom for free

The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...

Per Hammargren, Sales Director, ICU Scandinavia AB

Why are you going to Scanlab and Biotech Forum?

Hon tar plats på höjdarlista

Varje år samlar den ledande vetenskapliga tidskriften Genetic Engineering News tio namn på de mest lovande ledarna inom affärsvärlden och akademin under 40 år.

Webinar: Medtech quality and regulatory compliance

This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...

Fewer visitors but satisfied exhibitors

Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.

How to get the most out of the fair

“Fetmamedicinernas King Kong” närmare lansering i Storbritannien

Läkemedlet Mounjaro kan rulla ut på marknaden i Storbritannien “inom veckor”. Detta sedan brittiska läkemedelsverket blivit först i världen med att godkänna inj...